Enfusion Results Presentation Deck

*:enfusion ENFUSION, INC. CONSOLIDATED BALANCE SHEETS (dollars in thousands, except shares and unit amounts and par value) (Unaudited) ASSETS Current Assets: Cash and cash equivalents Accounts receivable, net Prepaid expenses Other current assets Total current assets Property and equipment, net Right of use asset Other assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable Accrued expenses and other current liabilities Lease liability - short term Total current liabilities Lease liability Other liabilities Total liabilities Stockholders' Equity: Class A common stock, $0.001 par value; 1,000,000,000 shares authorized, 70,859,711 and 65,583,289 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively Class B common stock, $0.001 par value; 150,000,000 shares authorized, 43,198,768 and 47,470,972 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss Total stockholders' equity attributable to Enfusion, Inc. Non-controlling interests Total stockholders' equity Total liabilities and stockholders' equity $ $ $ $ 2022 December 31, 62,545 25,855 6,105 2,303 96,808 15,759 6,732 4,484 123,783 1,685 11,665 4,030 17,380 2,959 20,339 71 $ $ $ 43 244,260 (178,863) (504) 65,007 38,437 103,444 123,783 $ 2021 64,365 18,223 6,030 1,060 89,678 13,051 PROPRIETARY AND CONFIDENTIAL 3,356 106,085 2,528 5,578 8,106 538 8,644 66 47 226,717 (171,209) (325) 55,296 42,145 97,441 106,085 Ⓒ2023 ENFUSION. ALL RIGHTS RESERVED. 15

View entire presentation